Technical Analysis for STTK - Shattuck Labs, Inc.

Grade Last Price % Change Price Change
F 30.75 8.93% 2.52
STTK closed up 8.93 percent on Monday, April 12, 2021, on 1.52 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical STTK trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 8.93%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 8.93%
MACD Bullish Signal Line Cross Bullish 8.93%
Spinning Top Other 8.93%
Outside Day Range Expansion 8.93%
Older End-of-Day Signals for STTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 3 hours ago
1.5x Volume Pace about 7 hours ago
60 Minute Opening Range Breakout about 7 hours ago
Rose Above Previous Day's High about 7 hours ago
Rose Above 10 DMA about 7 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian cancer. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was founded in 2016 and is headquartered in Austin, Texas.
Classification

Sector: Other
Industry: Other
Keywords: Biotechnology Cancer Life Sciences Pharmaceutical Industry Solid Tumors Treatment Of Cancer Lymphoma Autoimmune Disease Clinical Research Clinical Trial Ovarian Cancer Takeda Pharmaceutical Company Advanced Solid Tumors Clinical Pharmacology Treatment Of Ovarian Cancer

Is STTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 60.5162
52 Week Low 17.51
Average Volume 112,368
200-Day Moving Average 0.00
50-Day Moving Average 38.71
20-Day Moving Average 31.42
10-Day Moving Average 28.70
Average True Range 3.20
ADX 34.84
+DI 16.98
-DI 22.66
Chandelier Exit (Long, 3 ATRs ) 31.33
Chandelier Exit (Short, 3 ATRs ) 35.17
Upper Bollinger Band 38.18
Lower Bollinger Band 24.65
Percent B (%b) 0.45
BandWidth 43.04
MACD Line -2.90
MACD Signal Line -3.17
MACD Histogram 0.2769
Fundamentals Value
Market Cap 1.28 Billion
Num Shares 41.7 Million
EPS
Price-to-Sales 115.04
Price-to-Book 10.37
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.39
Resistance 3 (R3) 35.91 33.54 35.45
Resistance 2 (R2) 33.54 32.11 33.79 35.14
Resistance 1 (R1) 32.15 31.22 32.85 32.63 34.82
Pivot Point 29.78 29.78 30.13 30.03 29.78
Support 1 (S1) 28.39 28.35 29.09 28.87 26.68
Support 2 (S2) 26.02 27.46 26.27 26.36
Support 3 (S3) 24.63 26.02 26.05
Support 4 (S4) 25.11